Intel has launched its Core Series 2 processor, an industrial-ready platform engineered for mission-critical edge applications, delivering breakthrough deterministic performance. Additionally, Intel is expanding its Edge AI portfolio with a sixth suite targeting healthcare applications.
This launch signifies Intel's commitment to the growing edge computing and AI markets. The deterministic performance of the Core Series 2 is crucial for industrial and mission-critical applications, while the expansion into healthcare AI addresses a significant growth sector. This strengthens Intel's competitive position in specialized computing markets.
Intel Core Series 2 processor launched for edge applications.
Offers deterministic performance for industrial use.
Expanded Edge AI portfolio with a healthcare-focused suite.
This launch has global relevance, particularly for industrial automation and healthcare technology sectors in regions like North America, Europe, and East Asia.
Offers deterministic performance for industrial use.
Expanded Edge AI portfolio with a healthcare-focused suite.
Sign in to save notes on signals.
Sign In